Document is current
Any future updates will be listed below
-
Authors
Yanagisawa, Rina https://orcid.org/0009-0004-5434-6717
Inose, Ryo https://orcid.org/0000-0003-4874-0377
Muraki, Yuichi https://orcid.org/0000-0001-6951-5676
- License Information
-
More Information
Article History
Received: 31 July 2025
Accepted: 24 October 2025
First Online: 25 November 2025
Declarations
:
: This study was approved by the Institutional Review Board of the Kyoto Pharmaceutical University (Approval Number: E-00028). Informed consent was not required because the data were anonymized.
: Not applicable.
: RI received funding for the commissioned research from the Kowa Company, Ltd. However, this study was not directly funded. YM received grants from Pfizer Japan Inc.; Kowa Company Ltd.; the Japan Pharmaceutical Association; the Japan Society for the Promotion of Science; and the Ministry of Health, Labour and Welfare. YM is also a board member of the Japanese Society of Pharmaceutical Health Care and Sciences and the Japanese Society for Infection Prevention and Control, and a committee member of the AMR Clinical Reference Center. However, this study was not directly funded. The other authors have no conflicts of interest to declare.
